https://www.selleckchem.com/products/a2ti-1.html
MEL intake prevented the decrease in NK and CD8 T-lymphocytes, increased the proportion of CD4 T-lymphocytes at T1 and T2 compared to T0 (p = 0.002, d = 1.18; p = 0.001, d = 1.04, respectively) and decreased the proportion of CD14 CD16 Monocytes at T2 compared to T0 (p = 0.02, d = 1.57) in peripheral blood during HD therapy. Similar results were found in [EX + MEL] and [EX + PLA] conditions. This pilot study provides the first evidence that MEL intake alone or associated with intradialytic exercise displays potential immunoregulatory and
Like
Comment
Share
